Literature DB >> 18355382

The story of the discovery of heparin and warfarin.

Douglas Wardrop1, David Keeling.   

Abstract

Heparin and coumarins have been the mainstay of anticoagulant therapy throughout our working lives. As we stand on the threshold of a new era of anticoagulants it is timely to look back upon their discovery and development. Both have fascinating stories to tell. Jay McLean claimed to have discovered heparin whilst a medical student, although this is disputed. The story of warfarin leads us from a mysterious haemorrhagic disease of cattle to the development of a rat poison which became one of the most commonly prescribed drugs in history. Many people were involved in both stories and we owe them all a debt of gratitude.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18355382     DOI: 10.1111/j.1365-2141.2008.07119.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  59 in total

Review 1.  Practical issues with vitamin K antagonists: elevated INRs, low time-in-therapeutic range, and warfarin failure.

Authors:  Andrea Lee; Mark Crowther
Journal:  J Thromb Thrombolysis       Date:  2011-04       Impact factor: 2.300

2.  Heparin impairs angiogenic signaling and compensatory lung growth after left pneumonectomy.

Authors:  Duy T Dao; Lorenzo Anez-Bustillos; Jared Ourieff; Amy Pan; Paul D Mitchell; Hiroko Kishikawa; Gillian L Fell; Meredith A Baker; Randolph S Watnick; Hong Chen; Thomas E Hamilton; Michael S Rogers; Diane R Bielenberg; Mark Puder
Journal:  Angiogenesis       Date:  2018-06-28       Impact factor: 9.596

3.  Matching taxpayer funding to population health needs: not so simple.

Authors:  Michael S Lauer; David Gordon; Michelle Olive
Journal:  Circ Res       Date:  2015-04-10       Impact factor: 17.367

Review 4.  Biosimilars of low molecular weight heparins: Relevant background information for your drug formulary.

Authors:  Jacobus R B J Brouwers; Jeanine E Roeters van Lennep; Maarten J Beinema
Journal:  Br J Clin Pharmacol       Date:  2019-09-04       Impact factor: 4.335

Review 5.  Superwarfarin (Long-Acting Anticoagulant Rodenticides) Poisoning: from Pathophysiology to Laboratory-Guided Clinical Management.

Authors:  Yeow-Kuan Chong; Tony Wing-Lai Mak
Journal:  Clin Biochem Rev       Date:  2019-11

6.  Effect of Left Ventricular Systolic Dysfunction on Response to Warfarin.

Authors:  Sameer Ather; Aditi Shendre; T Mark Beasley; Todd Brown; Charles E Hill; Sumanth D Prabhu; Nita A Limdi
Journal:  Am J Cardiol       Date:  2016-05-05       Impact factor: 2.778

Review 7.  The emerging threat of superwarfarins: history, detection, mechanisms, and countermeasures.

Authors:  Douglas L Feinstein; Belinda S Akpa; Manuela A Ayee; Anne I Boullerne; David Braun; Sergey V Brodsky; David Gidalevitz; Zane Hauck; Sergey Kalinin; Kathy Kowal; Ivan Kuzmenko; Kinga Lis; Natalia Marangoni; Michael W Martynowycz; Israel Rubinstein; Richard van Breemen; Kyle Ware; Guy Weinberg
Journal:  Ann N Y Acad Sci       Date:  2016-05-31       Impact factor: 5.691

8.  Utilization rates of enoxaparin and heparin in deep venous thrombosis prophylaxis after education and electronic order change at a single institution: a quality improvement study.

Authors:  Linda Hoang; Shahidul Islam; Alexander Hindenburg
Journal:  J Thromb Thrombolysis       Date:  2018-11       Impact factor: 2.300

9.  VKORC1-1639A allele influences warfarin maintenance dosage among Blacks receiving warfarin anticoagulation: a retrospective cohort study.

Authors:  Fatima Donia Mili; Tenecia Allen; Paula Weinstein Wadell; W Craig Hooper; Christine De Staercke; Christopher J Bean; Cathy Lally; Harland Austin; Nanette K Wenger
Journal:  Future Cardiol       Date:  2017-12-08

Review 10.  A review of the role of anticoagulation in the treatment of peripheral arterial disease.

Authors:  Thomas F Whayne
Journal:  Int J Angiol       Date:  2012-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.